Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients (Q36086834)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients |
scientific article |
Statements
1 reference
Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients (English)
1 reference
A Battaglia
A M Di Giacomo
G C Antonini Cappellini
F De Galitiis
G Amato
A Lazzeri
1 reference
1 reference
1 reference